Literature DB >> 35084690

Thymidine Kinase 2 and Mitochondrial Protein COX I in the Cerebellum of Patients with Spinocerebellar Ataxia Type 31 Caused by Penta-nucleotide Repeats (TTCCA)n.

Hanako Aoki1, Miwa Higashi1, Michi Okita1, Noboru Ando2, Shigeo Murayama3,4, Kinya Ishikawa5, Takanori Yokota1.   

Abstract

Spinocerebellar ataxia type 31 (SCA31), an autosomal-dominant neurodegenerative disorder characterized by progressive cerebellar ataxia with Purkinje cell degeneration, is caused by a heterozygous 2.5-3.8 kilobase penta-nucleotide repeat of (TTCCA)n in intron 11 of the thymidine kinase 2 (TK2) gene. TK2 is an essential mitochondrial pyrimidine-deoxyribonucleoside kinase. Bi-allelic loss-of-function mutations of TK2 lead to mitochondrial DNA depletion syndrome (MDS) in humans through severe (~ 70%) reduction of mitochondrial electron-transport-chain activity, and tk2 knockout mice show Purkinje cell degeneration and ataxia through severe mitochondrial cytochrome-c oxidase subunit I (COX I) protein reduction. To clarify whether TK2 function is altered in SCA31, we investigated TK2 and COX I expression in human postmortem SCA31 cerebellum. We confirmed that canonical TK2 mRNA is transcribed from exons far upstream of the repeat site, and demonstrated that an extended version of TK2 mRNA ("TK2-EXT"), transcribed from exons spanning the repeat site, is expressed in human cerebellum. While canonical TK2 was conserved among vertebrates, TK2-EXT was specific to primates. Reverse transcription-PCR demonstrated that both TK2 mRNAs were preserved in SCA31 cerebella compared with control cerebella. The TK2 proteins, assessed with three different antibodies including our original polyclonal antibody against TK2-EXT, were detected as ~ 26 kilodalton proteins on western blot; their levels were similar in SCA31 and control cerebella. COX I protein level was preserved in SCA31 compared to nuclear DNA-encoded protein. We conclude that the expression and function of TK2 are preserved in SCA31, suggesting a mechanism distinct from that of MDS.
© 2021. The Author(s).

Entities:  

Keywords:  Cytochrome-c oxidase (COX); Mitochondria; Mitochondrial DNA depletion syndrome (MDS); Purkinje cell; Spinocerebellar ataxia type 31 (SCA31); Thymidine kinase 2 (TK2)

Year:  2022        PMID: 35084690     DOI: 10.1007/s12311-021-01364-2

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.847


  29 in total

1.  Pentanucleotide repeats at the spinocerebellar ataxia type 31 (SCA31) locus in Caucasians.

Authors:  K Ishikawa; A Dürr; T Klopstock; S Müller; B De Toffol; M Vidailhet; A Vighetto; C Marelli; H-E Wichmann; T Illig; Y Niimi; N Sato; T Amino; G Stevanin; A Brice; H Mizusawa
Journal:  Neurology       Date:  2011-11-02       Impact factor: 9.910

2.  Cloning and expression of human deoxyguanosine kinase cDNA.

Authors:  M Johansson; A Karlsson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

3.  A clinical, genetic, and neuropathologic study in a family with 16q-linked ADCA type III.

Authors:  K Owada; K Ishikawa; S Toru; G Ishida; M Gomyoda; O Tao; Y Noguchi; K Kitamura; I Kondo; E Noguchi; T Arinami; H Mizusawa
Journal:  Neurology       Date:  2005-08-23       Impact factor: 9.910

4.  Natural History of Spinocerebellar Ataxia Type 31: a 4-Year Prospective Study.

Authors:  Katsuya Nakamura; Kunihiro Yoshida; Akira Matsushima; Yusaku Shimizu; Shunichi Sato; Hiroyuki Yahikozawa; Shinji Ohara; Masanobu Yazawa; Masao Ushiyama; Mitsuto Sato; Hiroshi Morita; Atsushi Inoue; Shu-Ichi Ikeda
Journal:  Cerebellum       Date:  2017-04       Impact factor: 3.847

5.  The chromosome 16q-linked autosomal dominant cerebellar ataxia (16q-ADCA): A newly identified degenerative ataxia in Japan showing peculiar morphological changes of the Purkinje cell: The 50th Anniversary of Japanese Society of Neuropathology.

Authors:  Kinya Ishikawa; Hidehiro Mizusawa
Journal:  Neuropathology       Date:  2010-10       Impact factor: 1.906

6.  Analysis of an insertion mutation in a cohort of 94 patients with spinocerebellar ataxia type 31 from Nagano, Japan.

Authors:  Haruya Sakai; Kunihiro Yoshida; Yusaku Shimizu; Hiroshi Morita; Shu-ichi Ikeda; Naomichi Matsumoto
Journal:  Neurogenetics       Date:  2010-04-28       Impact factor: 2.660

7.  Abnormal RNA structures (RNA foci) containing a penta-nucleotide repeat (UGGAA)n in the Purkinje cell nucleus is associated with spinocerebellar ataxia type 31 pathogenesis.

Authors:  Yusuke Niimi; Makoto Takahashi; Emiko Sugawara; Shigeaki Umeda; Masato Obayashi; Nozomu Sato; Taro Ishiguro; Miwa Higashi; Yoshinobu Eishi; Hidehiro Mizusawa; Kinya Ishikawa
Journal:  Neuropathology       Date:  2013-04-22       Impact factor: 1.906

8.  Spinocerebellar ataxia type 31 is associated with "inserted" penta-nucleotide repeats containing (TGGAA)n.

Authors:  Nozomu Sato; Takeshi Amino; Kazuhiro Kobayashi; Shuichi Asakawa; Taro Ishiguro; Taiji Tsunemi; Makoto Takahashi; Tohru Matsuura; Kevin M Flanigan; Sawa Iwasaki; Fumitoshi Ishino; Yuko Saito; Shigeo Murayama; Mari Yoshida; Yoshio Hashizume; Yuji Takahashi; Shoji Tsuji; Nobuyoshi Shimizu; Tatsushi Toda; Kinya Ishikawa; Hidehiro Mizusawa
Journal:  Am J Hum Genet       Date:  2009-10-29       Impact factor: 11.025

Review 9.  Founder Effects of Spinocerebellar Ataxias in the American Continents and the Caribbean.

Authors:  Roberto Rodríguez-Labrada; Ana Carolina Martins; Jonathan J Magaña; Yaimeé Vazquez-Mojena; Jacqueline Medrano-Montero; Juan Fernandez-Ruíz; Bulmaro Cisneros; Helio Teive; Karen N McFarland; Maria Luiza Saraiva-Pereira; César M Cerecedo-Zapata; Christopher M Gomez; Tetsuo Ashizawa; Luis Velázquez-Pérez; Laura Bannach Jardim
Journal:  Cerebellum       Date:  2020-06       Impact factor: 3.847

10.  Regulatory Role of RNA Chaperone TDP-43 for RNA Misfolding and Repeat-Associated Translation in SCA31.

Authors:  Taro Ishiguro; Nozomu Sato; Morio Ueyama; Nobuhiro Fujikake; Chantal Sellier; Akemi Kanegami; Eiichi Tokuda; Bita Zamiri; Terence Gall-Duncan; Mila Mirceta; Yoshiaki Furukawa; Takanori Yokota; Keiji Wada; J Paul Taylor; Christopher E Pearson; Nicolas Charlet-Berguerand; Hidehiro Mizusawa; Yoshitaka Nagai; Kinya Ishikawa
Journal:  Neuron       Date:  2017-03-23       Impact factor: 17.173

View more
  1 in total

1.  Inflammasome Inhibition Prevents Motor Deficit and Cerebellar Degeneration Induced by Chronic Methamphetamine Administration.

Authors:  Jiuyang Ding; Lingyi Shen; Yuanliang Ye; Shanshan Hu; Zheng Ren; Ting Liu; Jialin Dai; Zhu Li; Jiawen Wang; Ya Luo; Qiaojun Zhang; Xiali Zhang; Xiaolan Qi; Jiang Huang
Journal:  Front Mol Neurosci       Date:  2022-04-01       Impact factor: 6.261

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.